Applicant, as named in the Orange Book

Corstasis Therap

Next listed expiry: Enbumyst on 14 May 2045. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Enbumyst bumetanide	bumetanide	219500	14 May 2045	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.